Methods for estimating HIV prevalence: A comparison of extrapolation from surveys on infection rate and risk behaviour with back-calculation for the Netherlands

European Journal of Epidemiology

Volumn 14, Issue 7, 1998, Pages 645-652

  Houweling, Hans ^a   Heisterkamp, Siem H ^a   Wiessing, Lucas G ^a   Coutinho, Roel A ^b   Van Wijngaarden, Jan K ^c   Jager, Hans C ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

^c Inspectorate for Health Care   (Netherlands)

Author keywords

AIDS; Back calculation; Exposure group; HIV; Methodology; Prevalence

Indexed keywords

ADULT; ARTICLE; BISEXUALITY; BLOOD TRANSFUSION; FEMALE; HEALTH SURVEY; HEMOPHILIA; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; STATISTICAL ANALYSIS;

ADULT; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; MALE; NETHERLANDS; POPULATION SURVEILLANCE; RISK FACTORS; RISK-TAKING;

EID: 0031768944     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007495607520     Document Type: Article

References (42)

1. Buehler JW, De Cock KM, Brunet JB. Surevillance definitions for AIDS. AIDS 1993; 7 (Suppl 1): S73-S81.
2. Mertens TE, Burton A, Stoneburner R, et al. Global estimates and epidemiology of HIV infections and AIDS. AIDS 1994; 8 (Suppl 1): S361-372.
3. Report of a working Group. The incidence and prevalence of AIDS and other severe HIV disease in England and Wales for 1992-1997: Projections using data to the end of June 1992. Communicable Disease Report 1993; 3 (Suppl 1): S1-S17.
4. Giesecke J, Johnson A, Hawkins A, et al. An estimate of the prevalence of human immunodeficiency virus infection in England and Wales by using a direct method. Journal of the Royal Statistical Society 1994; 157: 89-103.
5. van Duynhoven YTHP, Houweling H, Wiessing LG, Esveld MI, Nieste HLJ, Katchaki JN. Laboratory-based HIV surveillance with information on exposure: Importance of discriminating person-based from test-based results. Intern J STD AIDS 1996; 7: 117-122.
6. Hull H, Bettinger C, Gallaher M, Keller N, Wilson J, Mertz G. Comparison of IIIV-antibody prevalence in patients consenting and declining HIV-antibody testing in an STD clinic. JAMA 1988; 260: 935-938.
7. Jones JL, Hutto P, Meyer P, Dowda H, Gamble WB, Gunn RA. HIV seroprevalence and reasons for refusing and accepting HIV testing. Sex Transm Dis 1993; 20: 334-337.
8. Groseclose SL, Erickson B, Quinn TC, Glasser D, Campbell CH, Hook EW. Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public health sexually transmitted diseases clinics. Sex Transm Dis 1994; 21: 31-35.
9. Postema EJ, Willems PWJM, de Ridder MAJ, van der Meijden WI. Comparison of patients refusing with patients accepting anonymous HIV testing in an outpatient STD department in the Netherlands. Intern J STD AIDS, 1997; 8: 368-72.
10. Fennema JSA, van Ameijden EJC, Henquet CJM, van Doornum GJJ, Coutinho RA, van den Hoek JAR. IIIV-surveillance op een polikliniek voor seksuecl over-draagbare aandoeningen in Amsterdam, 1991-94; lage en stabiele prevalentie onder heteroseksuele bezoekcrs. Ned Tijdschr Geneeskd 1995; 139: 1595-1598.
11. Wiessing LG, Houweling H, Sandfort ThGM, Schop W, Bosga MB, van den Akker R. HIV-infectie in een Nederlandse groep homoseksuele mannen. Report nr. 529002001. Bilthoven: National Institute of Public Health and Environmental Protection (RIVM), 1993.
12. Houweling II. IIIV prevalence in selected populations, and selection by setting and study design compared to all people in category, the Netherlands: Amsterdam and outside, 1981-1997. In: Houweling H, Public health surveillance of AIDS and HIV infection in the Netherlands and Europe (thesis University of Amsterdam). Delft: Eburon Publishers, 1997: 197-204.
13. Hemofilie en AIDS. Badhoevedorp: Nederlandse Vereniging van Hemofilie-patiënten, 1994.
14. Veugelers PJ, van Zessen G, Hendriks JCM, Sandfort TGM, Coutinho RA, van Griensven GJP. Estimation of the magnitude of the HIV epidemic among homosexual men: utilization of survey data in predictive models. Eur J Epidemiol 1993; 9: 436-441.
15. van Zessen G, Sandfort T, eds. Seksualiteit in Nederland; seksucel gedrag, risico en preventie van AIDS. Amsterdam/Lisse: Swets & Zeitlinger, 1991.
16. Driessen FMHM. Methadonverstrekking in Nederland. Rijswijk/Utrecht: Bureau Driessen, 1990.
17. van Brussel GHA, van Lieshout SJM. Jaarverslag drugsafdeling 1992. Amsterdam: Municipal Health Service, Department of Mental Health, 1993.
18. Downs AM, Heisterkamp SH, Brunet JB, Hamers FF. Reconstruction and prediction of the HIV/AIDS epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe. AIDS 1997; 11: 649-62.
19. Heisterkamp SH, Jager JC, Ruitenberg EJ, et al. Correcting reported AIDS incidence: A statistical approach. Stat Med 1989; 8: 963-976.
20. Heisterkamp SH, Downs AM, van Houwelingen JC. Empirical Bayesian estimators for reconstruction of HIV incidence and prevalence and forecasting of AIDS; method of estimation, In: Quantitative analysis of AIDS/HIV: development of methods to support policy making for infectious disease control. Thesis University of Leiden, 1995.
21. Hendriks JCM, Satten GA, Longini IM, van Druten HAM, Schellekens PT, Coutinho RA. Use of immunological markers and continuous-lime Markov models to estimate progression of HIV infection in homosexual men. AIDS 1996; 10: 649-56.
22. Hendriks JCM, Satten GA, van Ameijden EJC, van Druten HAM, Coutinho RA, van Griensven GJP. The incubation period to AIDS among injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis. AIDS (In press).
23. Houweling H, Hamers FF, Termorshuizen F, Gill ON, Jager JC, Coutinho RA. A birth cohort analysis of AIDS in Europe: High incidence among young persons at risk. AIDS 1998; 12: 85-93.
24. Multicohort Analysis Project. Immunological markers of AIDS progression: Consistency across five IIIV-infected cohorts: Multicohort Analysis Project Workshop. part 1. AIDS 1994; 8: 911-921.
25. Veugelers PJ, van Zessen G, Sandfort ThGM, Cornelisse-Claassen TM, van Griensven GJP. Seksualiteit en risicogedrag van Amsterdamse mannen. Tijdschrift voor Sociale Gezondheidszorg 1992; 70: 87-94.
26. College voor de Bloedtransfusie. Overzicht van de bloedtransfusie in Nederland, 1995. Amsterdam: College voor de Bloedtransfusie of the Netherlands Red Cross, 1997.
27. Houweling H, Termorshuizen F, Bindels PJE, van Wijngaarden JK. The AIDS epidemic in the Netherlands 1982-1996. In: Houweling H, Public health surveillance of AIDS and HIV infection in the Netherlands and Europe (thesis University of Amsterdam). Delft: Eburon Publishers, 1997: 87-105.
28. van Griensven GJP, de Vroome EMM, Goudsmit J, Coutinho RA. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. Br Med J 1989; 298: 218-221.
29. van den Hoek JAR, Coutinho RA, van Haastrecht HJA, van Zadelhof AW, Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988; 2: 55-60.
30. Gibbs DA, Hamill DN, Magruder-Habib K. Populations at increased risk of HIV infection: Current knowledge and limitations. J Acquir Immune Defic Syndr 1991; 4: 881-889.
31. Jager JC, Heisterkamp SH, Brookmeyer R: AIDS surveillance and prediction of the HIV and AIDS epidemic: Methodological developments. AIDS 1993; 7 (Suppl 1): S67-71.
32. Brookmeyer R, Gail MH. Back-calculation. In: AIDS Epidemiology, a quantitative approach. New York/Oxford: Oxford University Press, 1994.
33. The incidence and prevalence of AIDS and other severe IIIV disease in England and Wales for 1992-1997; projections using data to the end of June 1992. Comm Dis Rep 1993; 3 (Suppl 1); S1-17.
34. van Haastrecht HJA, van den Hoek JAR, Coutinho RA. High mortality among HIV-infected injecting drug users without AIDS diagnosis: Implications for HIV-infection modellers? AIDS 1994; 8: 363-366.
35. Seydel J, Krämer, Rosenberg PS, Wittkowski KM, Gail MH. Backcalculation of the number infected with human immunodeficiency virus in Germany. J Acquir Immune Defic Syndr 1994; 7: 74-78.
36. Bacchetti P, Segal MR, Hessol NA, Jewell NP. Different AIDS incubation periods and their impact on reconstructing human immunodeficiency virus epidemics and projecting AIDS incidence. Proc Natl Acad Sci USA 1993; 90: 2194-2196.
37. Pezzotti P, Phillips AN, Dorrucci M, et al. Category of exposure to HIV and age in the progression to AIDS: Longitudinal study of 1199 people with known dates of seroconversion. Br Med J 1996; 313: 583-6.
38. Spijkerman IJB, Langendam MW, Veugelers PJ, et al. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion. Epidemiology 1996; 7: 571-7.
39. Hoover DR, The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease; a review of the literature. Drugs 1995; 49: 20-36.
40. Termorshuizen F, Houweling H. HIV/aids in Nederland: Betere behandelingsmogelijkheden maken HIV-in plaats van aidssurveillance noodzakelijk. Ned Tijdschr Geneeskd 1997; 141: 1928-9.
41. de Wit JBF, van den Hoek JAR, Sandfort ThGM, van Griensven GJP. Increase in unprotected anogenital intercourse among homosexual men. Am J Publ Health 1993; 83: 1451-1453.
42. Hoover DR, Muñoz A, Carey V, et al. Estimating the 1978-1990 and future spread of human immunodeficiency virus type 1 in subgroups of homosexual men. Am J Epidemiol 1991; 134: 1190-1205.